Showing results (1261-1270 of 1,523) with videos related to

Sort By:
Pageof 153
Oncotarget|June 5, 2016
The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancerLan-Ying Gou, An-Na Li, Jin-Ji Yang, et al.
CNS Neuroscience & Therapeutics|August 21, 2012
Age differences in clinical characteristics, health care, and outcomes after ischemic stroke in ChinaYa-Xian Deng, Yi-Long Wang, Bao-Qin Gao, et al.
Nature Communications|February 3, 2026
Dual-Band Infrared PbS Colloidal Quantum Dot Focal Plane ArrayYunxiang Di, Kun Ba, Lingfeng Ye, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
Lung Cancer (Auckland, N.Z.)|May 14, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung CancerSi-Yang Maggie Liu, Zhi Xie, Lixu Yan, et al.
Mbio|October 7, 2025
Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidityJia-Yu Du, Zhen-Jie Zhang, Li Tan, et al.
Ebiomedicine|September 14, 2020
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinomaHao Sun, Si-Yang Liu, Jia-Ying Zhou, et al.
Therapeutic Advances in Medical Oncology|April 28, 2023
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patientsZhen Wang, Xu-Chao Zhang, Wei-Neng Feng, et al.
British Journal of Haematology|January 18, 2021
High infiltration of CD20+ B lymphocytes in extranodal natural killer/T-cell lymphoma is associated with better prognosisMin-Min Chen, Guo-Peng Zeng, Jing Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker AnalysesTony S K Mok, Sang-We Kim, Yi-Long Wu, et al.
Pageof 153